The biotech sector was in focus last week, with regular pipeline and regulatory updates. Drug approvals were in the spotlight as well. Here's a recap of the week’s most important stories: Biogen, UCB ...
Source LinkThe biotech sector was in focus last week, with regular pipeline and regulatory updates. Drug approvals were in the spotlight as well. Here's a recap of the week’s most important stories: Biogen, UCB ...
Source Link
Comments